Suppr超能文献

利用 CRISPR/Cas9 构建点突变兔。

Construction of point mutation rabbits using CRISPR/Cas9.

机构信息

Jiangsu Provincial Research Center for Animal Transgenesis and Biopharming.

出版信息

Zhejiang Da Xue Xue Bao Yi Xue Ban. 2021 Apr 25;50(2):229-238. doi: 10.3724/zdxbyxb-2021-0133.

Abstract

To establish a rabbit model of proprotein convertase subtilisin/kexin type9 () point mutation with CRISPR/Cas9 gene editing technique. According to the PubMed gene protein data, the PCSK9 protein functional regions of human and rabbit were analyzed by Blast. The 386S (Ser) amino acid functional region of human gene was homologous to the 485S of rabbit gene. Three small guide RNAs and one single-stranded donor oligonucleotide were designed according to the 485S base substitution position and sequence analysis of rabbit gene. The synthetic small guide RNAs, Cas9 mRNA and single-stranded donor oligonucleotide were co-injected into the cytoplasm of rabbit fertilized eggs and the embryos were transferred into the pregnant rabbits. PCR, TA cloning and off-target analysis were performed on the F0 rabbits to identify whether the PCSK9 mutation was successful. Fifteen F0 rabbits were obtained. The sequencing results showed that one of them was PCSK9 point mutation homozygote and two of them were PCSK9 point mutation heterozygotes, and the mutation could be stably inherited. The rabbit model of PCSK9 point mutation was successfully constructed by CRISPR/Cas9 technique, which provides an animal model for exploring the molecular mechanism of impaired PCSK9 function and developing reliable and effective diagnosis and treatment measures.

摘要

建立应用 CRISPR/Cas9 基因编辑技术的载脂蛋白转化酶枯草溶菌素 9(PCSK9)点突变兔模型。根据 PubMed 基因蛋白数据库,对人源和兔源 PCSK9 蛋白功能区进行 Blast 分析,发现人源基因的 386S(丝氨酸)氨基酸功能区与人源基因的 485S 同源,根据兔源基因 485S 碱基替换位置及序列分析,设计了 3 条小向导 RNA 和 1 条单链供体寡核苷酸。将合成的小向导 RNA、Cas9mRNA 和单链供体寡核苷酸共注射到兔受精卵的细胞质中,并将胚胎移植到妊娠母兔体内。对 F0 代兔进行 PCR、TA 克隆及脱靶分析,以鉴定 PCSK9 突变是否成功。共获得 15 只 F0 代兔,测序结果显示其中 1 只为 PCSK9 点突变纯合子,2 只为 PCSK9 点突变杂合子,突变可稳定遗传。应用 CRISPR/Cas9 技术成功构建了 PCSK9 点突变兔模型,为探索 PCSK9 功能受损的分子机制以及开发可靠有效的诊断和治疗措施提供了动物模型。

相似文献

1
Construction of point mutation rabbits using CRISPR/Cas9.
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2021 Apr 25;50(2):229-238. doi: 10.3724/zdxbyxb-2021-0133.
3
In Vivo Base Editing of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) as a Therapeutic Alternative to Genome Editing.
Arterioscler Thromb Vasc Biol. 2017 Sep;37(9):1741-1747. doi: 10.1161/ATVBAHA.117.309881. Epub 2017 Jul 27.
4
CRISPR-Cas9 Targeting of PCSK9 in Human Hepatocytes In Vivo-Brief Report.
Arterioscler Thromb Vasc Biol. 2016 May;36(5):783-6. doi: 10.1161/ATVBAHA.116.307227. Epub 2016 Mar 3.
6
Treatment of Dyslipidemia Using CRISPR/Cas9 Genome Editing.
Curr Atheroscler Rep. 2017 Jul;19(7):32. doi: 10.1007/s11883-017-0668-8.
8
In vivo genome and base editing of a human PCSK9 knock-in hypercholesterolemic mouse model.
BMC Biol. 2019 Jan 15;17(1):4. doi: 10.1186/s12915-018-0624-2.
10
[Establishment and verification of a mouse model of gene H435Y mutation].
Nan Fang Yi Ke Da Xue Xue Bao. 2018 Sep 30;38(10):1245-1249. doi: 10.3969/j.issn.1673-4254.2018.10.15.

引用本文的文献

本文引用的文献

1
PCSK9 loss-of-function variants and Lp(a) phenotypes among black US adults.
J Lipid Res. 2019 Nov;60(11):1946-1952. doi: 10.1194/jlr.P119000173. Epub 2019 Sep 11.
2
Impact of PCSK9 loss-of-function genotype on 1-year mortality and recurrent infection in sepsis survivors.
EBioMedicine. 2018 Dec;38:257-264. doi: 10.1016/j.ebiom.2018.11.032. Epub 2018 Nov 23.
3
PCSK9: A novel inflammation modulator in atherosclerosis?
J Cell Physiol. 2019 Mar;234(3):2345-2355. doi: 10.1002/jcp.27254. Epub 2018 Sep 24.
4
Role of PCSK9 in lipid metabolism and atherosclerosis.
Biomed Pharmacother. 2018 Aug;104:36-44. doi: 10.1016/j.biopha.2018.05.024. Epub 2018 May 11.
5
PCSK9: From Basic Science Discoveries to Clinical Trials.
Circ Res. 2018 May 11;122(10):1420-1438. doi: 10.1161/CIRCRESAHA.118.311227.
6
Prevention of cardiovascular disease: Much more is needed.
Eur J Prev Cardiol. 2018 Jul;25(10):1083-1086. doi: 10.1177/2047487318770297. Epub 2018 Apr 25.
8
Principles and Applications of Rabbit Models for Atherosclerosis Research.
J Atheroscler Thromb. 2018 Mar 1;25(3):213-220. doi: 10.5551/jat.RV17018. Epub 2017 Oct 19.
9
Delivery strategies of the CRISPR-Cas9 gene-editing system for therapeutic applications.
J Control Release. 2017 Nov 28;266:17-26. doi: 10.1016/j.jconrel.2017.09.012. Epub 2017 Sep 11.
10
Animal models of atherosclerosis.
Biomed Rep. 2017 Mar;6(3):259-266. doi: 10.3892/br.2017.843. Epub 2017 Jan 17.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验